跳至主要内容
临床试验/EUCTR2009-012750-21-FR
EUCTR2009-012750-21-FR进行中(未招募)不适用

Traitement des épidermolyses bulleuses dystrophiques héréditaires parl’épigallocatéchine-3-gallate oral (Polyphenon E®)

CHU de NICE0 个研究点开始时间: 2009年11月27日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
CHU de NICE

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
CHU de NICE

相似试验

进行中(未招募)
1 期
Traitement des épidermolyses bulleuses simples de type Dowling Maera par l'érythromicine oraleDowling Maera's bullous epidermolysis is a génodermatose with autosomique dominant transmission owed to transfers of the genes coding for keratins. It results from it a cutaneous fragility very severe especially during the early childhood. Tetracyclines showed a certain efficiency in cases isolated probably by their anti-inflammatory action but cannot be used at the young child's. The érythromycine, used in the other inflammatory dermatosis, seems to be a good candidate for these patients.MedDRA version: 12.1Level: LLTClassification code 10056508Term: Acquired epidermolysis bullosa
EUCTR2010-024428-10-FRCHU de NICE8
已完成
不适用
Recessive dystrophic epidermolysis bullosa: A clinical observational study of the (inner) eye.Butterfly disordercotton wool skin disordercrystal skin disordersevere heriditary blister disease1001592010042261
NL-OMON43115niversitair Medisch Centrum Groningen3
已完成
2 期
Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)Epidermolysis Bullosa Dystrophica
NCT00951964Centre Hospitalier Universitaire de Nice18
进行中(未招募)
1 期
Traitement du ptosis des dystrophies musculaires oculo-pharyngées par autogreffes de myoblastes.
EUCTR2015-001192-48-FRCHU CAE10
已完成
不适用
Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)Dystrophic Epidermolysis Bullosa
NCT04757727Centre Hospitalier Universitaire de Nice27